Cambridge, Massachusetts–based Ketryx, a software platform company that automates regulatory compliance for medical device and life sciences companies, has secured $39 million in Series B funding led by Transformation Capital, pushing its total raised to more than $55 million. The investment comes as the industry grapples with integrating AI into products amid tightening FDA rules,… The post Ketryx raises $39 million in Series B funding to expand AI compliance tools for life sciences appe...
